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Interleukin-22 (IL-22) plays a critical role in mucosal
defense, although the molecular mechanisms that
ensure IL-22 tissue distribution remain poorly under-
stood. We show that the CXCL16-CXCR6 chemo-
kine-chemokine receptor axis regulated group 3
innate lymphoid cell (ILC3) diversity and function.
CXCL16 was constitutively expressed by CX3CR1+
intestinal dendritic cells (DCs) and coexpressed
with IL-23 after Citrobacter rodentium infection. In-
testinal ILC3s expressed CXCR6 and its ablation
generated a selective loss of the NKp46+ ILC3
subset, a depletion of intestinal IL-22, and the
inability to control C. rodentium infection. CD4+
ILC3s were unaffected by CXCR6 deficiency and
remained clustered within lymphoid follicles. In
contrast, the lamina propria of Cxcr6/ mice was
devoid of ILC3s. The loss of ILC3-dependent IL-22
epithelial stimulation reduced antimicrobial peptide
expression that explained the sensitivity of Cxcr6/
mice to C. rodentium. Our results delineate a critical
CXCL16-CXCR6 crosstalk that coordinates the intes-
tinal topography of IL-22 secretion required for
mucosal defense.
INTRODUCTION
Innate lymphoid cells (ILCs) comprise a related set of hemato-
poietic effector cells that participate in immune defense and
tissue remodeling, especially at mucosal surfaces (reviewed
in Spits et al., 2013). Three groups of ILC can be defined based
on transcription factor requirements, cytokine production pro-
files, and roles in immunity (Spits and Di Santo, 2011). A first
group of ILC (ILC1) includes natural killer cells (NK cells) and
other interferon-g (IFN-g)-producing ILC that expresses the
transcription factor T-bet (Tbx21) and play important roles in
protection against viruses and intracellular pathogens (Bernink
et al., 2013; Gordon et al., 2012; Klose et al., 2014; Townsend776 Immunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc.et al., 2004). A second group of ILC (ILC2) includes ‘‘nuocytes’’
or natural helper cells that express the transcription factors
Gata-3 and RORa and produce interleukin-5 (IL-5) and IL-13
in response to parasitic infections, allergens, and viruses
(Moro et al., 2010; Neill et al., 2010; Price et al., 2010; Wong
et al., 2012). A third ILC group (ILC3) includes transcription
factor RORgt+ lymphoid-tissue inducer cells (LTi cells) and nat-
ural cytotoxicity receptor (NCR)-expressing cells that have pro-
tective roles against extracellular bacteria and fungi and can
be associated with organ-specific inflammation (Cella et al.,
2009; Cupedo et al., 2009; Luci et al., 2009; Sanos et al.,
2009; Satoh-Takayama et al., 2008; Sawa et al., 2010). These
different ILC groups have been identified in multiple tissues
and in the circulation (Spits and Di Santo, 2011). In most or-
gans, ILC subsets constitute a minor fraction of total lym-
phocytes; however, mucosal tissues represent the exception
because these sites harbor multiple ILC subsets under
steady-state conditions (Sonnenberg and Artis, 2012). The
mechanisms that regulate ILC tissue distribution under normal
conditions and during inflammation or infection are poorly
understood.
IL-22 is a member of the IL-10 family that plays multiple
roles in the regulation of various nonhematopoietic cells via
the IL-22 receptor complex expressed on diverse epithelial
cell types (enterocytes, goblet cells, Paneth cells) (reviewed
in Sabat et al., 2014). These epithelial subsets have distinct
anatomical functions and localizations within the intestinal
mucosa. An effective IL-22-dependent epithelial response
has critical consequences as illustrated by the absence of
mucosal barrier containment and severe susceptibility of
Il22/ mice to infection by Citrobacter rodentium or Klebseilla
pneumonia that can be reversed by exogenous administration
of the antimicrobial peptide RegIIIg (Aujla et al., 2008; Zheng
et al., 2008). This same mechanism might in part be involved
in the anatomical restriction of lymphoid-resident commensal
bacteria that can provoke systemic inflammation (Sonnenberg
et al., 2012). A better understanding of the signals that regu-
late localized IL-22 production could offer a means to limit
damage following infection and promote tissue remodeling
and repair.
Cellular sources of IL-22 include a variety of innate and
adaptive lymphocytes. In the case of C. rodentium infection,
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and protects recombinase-deficient mice lacking adaptive im-
munity (Zheng et al., 2008). Several groups have studied the
localization of RORgt+ IL-22-producing ILC3 subsets that differ-
entially express NKp46 and CD4. NKp46+ ILC3s are found in the
intestinal lamina propria (LP) but are rare in cryptopatches; these
cells lack CCR6 chemokine receptor expression and do not pro-
duce IL-17A (Satoh-Takayama et al., 2011; Satoh-Takayama
et al., 2008; Sawa et al., 2010). In contrast, CD4+ ILC3 (LTi cells
in fetal and adult) express CCR6, localize to cryptopatches and
isolated lymphoid follicles, and produce IL-17A (Klose et al.,
2013; Luci et al., 2009; Sawa et al., 2010). In addition, less
well-defined CD4NKp46 ILC3 subsets have been identified
that variably express T-bet and CCR6 (Buonocore et al., 2010;
Klose et al., 2013; Sawa et al., 2010). These IL-22-producing
ILC3 subsets share common features including a CD3CD127+
phenotype and requirement for RORgt expression in order to
develop and produce IL-22 (reviewed in (Spits et al., 2013)).
The identification of phenotypically and functionally distinct IL-
22-producing ILC3 subsets with different tissue localization
within mucosal surfaces raises questions about themechanisms
that control ILC3 localization within tissues and the importance
of directing IL-22 to discrete epithelial compartments.
Mononuclear phagocytes (MPs), comprising monocytes, den-
dritic cells (DCs), and macrophages are central coordinators of
adaptive immunity but also ‘‘crosstalk’’ with innate lymphocytes
(such as NK cells) in order to regulate their maturation and func-
tion. Subsets of functionally distinct intestinal lamina propria
macrophages and DC (CD11chi, MHC class IIhi cells) have
been identified based on expression of CD103, CD11b, and
CX3CR1 (Varol et al., 2010). CD103+CD11b+ DCs represent a
major population in the lamina propria that is an important pro-
ducer of IL-23 in response to bacterial PAMPs (Kinnebrew
et al., 2012). In contrast, CD103+CD11b lamina propria DCs
are potent inducers of regulatory T cells through a transforming
growth factor b and retinoic acid-dependent mechanism
(Coombes et al., 2007). Lastly, a subset of CD11chiMHC class
IIhi cells in the lamina propria has the CD103CD11b+ phenotype
with intermediate CX3CR1 expression (Cerovic et al., 2013).
These CX3CR1+ MPs express macrophage markers (F4/80,
CD64) and have high phagocytic activity but also show the ability
to form transepithelial dendrites (Chieppa et al., 2006; Niess
et al., 2005). Because intestinal macrophages and/or DCs are
potential sources of IL-23 that can regulate IL-22 production dur-
ing infection (Kinnebrew et al., 2012; Satpathy et al., 2013), the
regulated interactions of DCs, macrophages, and MPs with
diverse ILC subsets may represent an important mechanism to
maintain gut homeostasis. Lymphotoxins play an important
role in ILC regulation via intestinal DCs duringC. rodentium infec-
tion (Tumanov et al., 2011), and recent reports implicate
CX3CR1+ hematopoietic cells in the regulation of IL-22 produc-
tion in this context (Longman et al., 2014; Manta et al., 2013). In
contrast, little is known about the mechanisms that orchestrate
intestinal IL-22 topography.
Here we investigate the importance of the CXCL16-CXCR6
chemokine-chemokine receptor axis between CX3CR1+ DC
and ILC3 subsets in the orchestration of tissue-specific topog-
raphy of IL-22 secretion in the intestine under steady-state con-
ditions and in response to mucosal pathogens.IRESULTS
CX3CR1 Expression Is Required for Homeostasis of
IL-22-Producing ILC3
Our understanding of the signals that regulate ILC migration
within tissues is in its infancy. We analyzed whether myeloid
cells deliver chemokine signals that influence ILC3 positioning
and regulate steady-state ILC3 homeostasis. Resident macro-
phages and DCs in the gut differentially express the chemokine
receptor CX3CR1 (that binds fractalkine) and chemokine
signaling through CX3CR1 controls IL-22 production during
C. rodentium infection (Longman et al., 2014; Manta et al.,
2013). In order to study the influence of CX3CR1 expressing cells
on intestinal ILC3 homeostasis and function, we analyzed
CX3CR1-deficient mice (Jung et al., 2000). Frequencies and
absolute numbers of ILC3 (CD3CD127+RORgt+ cells) were
reduced in Cx3cr1gfp/gfp mice compared to controls that could
be accounted for by a significant 60% reduction in the absolute
numbers of NKp46+ ILC3 (Figures 1A and 1B). In contrast,
steady-state numbers of CD4+ and CD4NKp46 (double-nega-
tive or ‘‘DN’’) ILC3, ILC2 (CD3CD127+RORgtGata3hi), and
NK1.1+ NK cells were not changed (Figures 1A and 1B; data
not shown).
We next examined the influence of CX3CR1 deficiency on
cytokine production by ILC3 subsets. Because IL-23 production
from intestinal CD11b+ DCs can stimulate ILC3-dependent IL-22
production (Cox et al., 2012; Longman et al., 2014), we assessed
both constitutive and IL-23-induced IL-22 production from ILC3
subsets in vitro. Comparing Cx3cr1+/+ and Cx3cr1gfp/gfp mice,
we found that while percentages of the different ILC3 subsets
that constitutively produced IL-22 were decreased (Figure 1C),
the absolute numbers of IL-22-producing NKp46+ ILC3s were
reduced in the absence of CX3CR1 while CD4+ and DN ILC3
were unaffected (Figure 1D). When stimulated ex vivo with
IL-23, these differences between Cx3cr1+/+ and Cx3cr1gfp/gfp
mice were more obvious with an 80% decrease in the number
of NKp46+ ILC3 that could produce IL-22 (Figures 1E and 1F).
A trend toward lower numbers of IL-22+ DN ILC3 was also
observed although this was not significant. Since ILC3 subsets
fail to express CX3CR1 (see Figure S1A available online), these
results suggest that CX3CR1 expression is required for steady-
state and IL-23-inducible IL-22 production from diverse ILC3
subsets. The reduced IL-23 responsiveness of ILC3 subsets
was not due to changes in Il23r expression (Figure S1B).
Intestinal Chemokine CXCL16 Expression Is Regulated
by CX3CR1
Given the effects of CX3CR1 ablation on the homeostasis of IL-
22-producing intestinal ILC3, we hypothesized that CX3CR1+
myeloid cells might maintain ILC3 through elaboration of soluble
factors. We analyzed chemokine expression in isolated CD11b+
and CD11b intestinal DC subsets (MHC II+CD11chi cells) using
targeted microarrays. While CCL19 and CCL20 were expressed
at low amounts, we documented a strong expression of CXCL16
by CD11b+ DC and clear CXCL16 expression in CD11b— DC
(Figure 2A). Moreover, we found that CX3CR1 was critical for
Cxcl16 expression by CD11b+ DCs (Figure 2B) and further iden-
tified a role for CX3CR1 in regulating Il23a expression in intestinal
DCs (Figure 2B), confirming a recent report (Longman et al.,mmunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc. 777
AC
E F
D
B
Figure 1. Characterization of IL-22 Producing ILC3 Subsets in Small Intestine from Cx3cr1 Reporter Mice
(A) Analysis of ILC3s (CD3–CD127+RORgt+ cells) in small intestine lamina propria lymphocytes of Cx3cr1+/+ and Cx3cr1gfp/gfp mice. Numbers indicate percent of
gated CD3CD127+RORgt+ cells (left panels) and CD4 and NKp46 expressing ILC3 subsets (right panels).
(B) Absolute numbers of total ILC3, NKp46+ ILC3, CD4+ ILC3, and CD4NKp46 (DN) ILC3s from SI LPLs of Cx3Cr1+/+ and Cx3Cr1gfp/gfp mice.
(C and E) Analysis of IL-22 production by ILC3 subsets inCx3cr1+/+ andCx3cr1gfp/gfp mice. Boxes indicated percentages of positive cells. SI LPLswere stimulated
without (C) or with (E) IL-23 in vitro for 4 hr.
(D and F) Absolute numbers of IL-22-producing ILC3 subsets from Cx3Cr1+/+ and Cx3Cr1gfp/gfp mice stimulated without (D) or with (F) IL-23. Data are repre-
sentative of three independent experiments with n = 4–6 mice analyzed for each genotype. Data shown are mean values ± SEM. *, p value < 0.05. **p < 0.01. See
also Figure S1.
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Figure 2. The Chemokine CXCL16 Is Expressed by Intestinal CD11b+ cDCs
(A) Analysis of chemokine expression by subsets of intestinal MHC II+CD11c+ DCs from Rag2/ mice.
(B) Il23a (left) and Cxcl16 (right) expression in intestinal MHC II+CD11c+ DC subsets from Cx3cr1+/+ and Cx3cr1gfp/gfp mice. Three mice of each genotype were
analyzed.
(C) CD11b and CD103 expression on intestinal MHC II+CD11c+ DC cells from Cx3cr1+/+ and Cx3cr1gfp/gfp mice. Data are representative of three independent
experiments with four to six mice of each genotype analyzed.
(D) Absolute numbers of intestinal MHC II+CD11c+ DC subsets in Cx3cr1+/+ and Cx3cr1gfp/gfp mice.
(E) Cxcl16 expression in isolated intestinal MHC II+CD11c+ DC subsets from Cx3cr1+/+ mice prior to (open bars) or 5 days postinfection with C. rodentium (filled
bars). Cxcl16 expression in IECs is also shown. Three mice of each genotype were analyzed.
(F) Cxcl16 expression in isolated intestinal MHC II+CD11c+ DC subsets from Cx3cr1+/+ (open bars) or germ-free mice (filled bars). Four mice of each genotype
were analyzed. Data shown are mean values ± SEM. **p value < 0.01. ***p value < 0.001. See also Figure S2.
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CXCR6 Critical for ILC3 Localization and Function2014). Subsets of intestinal DCs (MHC II+CD11chi cells) have
been identified based on the CD103 and CD11b expression
(Varol et al., 2010). CX3CR1 expression by intestinal MHC II+
CD11chi cells was restricted to CD103CD11b+ cells (Varol
et al., 2010; Figure S2A). CX3CR1 deficiency clearly affected in-Itestinal myeloid cell homeostasis with a marked reduction in
absolute numbers of CD103CD11b+ intestinal DCs (Figures
2C and 2D). Steady-state Cxcl16 expression was highest in
CD103CD11b+ DCs, and Cxcl16 expression was strongly
induced in this subset in response to infection by the intestinalmmunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc. 779
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Figure 3. CXCR6 Is Essential for Homeostasis of Gut IL-22+NKp46+ ILC3s
(A) Analysis of chemokine receptor expression in sorted ILC cell subsets from SI LPLs of Rag2/RorcGFP mice.
(B) Cxcr6 expression (GFP) in ILC3 subsets (NKp46, CD4, and DN) from the SI LPLs of Cxcr6gfp/+ mice.
(C) IL-22 expression in ILC3 subsets from Cxcr6gfp/+ mice. IL-22 versus Cxcr6 expression (GFP) is shown in IL-23 stimulated NKp46, CD4, and DN ILC3 subsets.
(D) Absolute numbers of IL-22+ NKp46, CD4, or DN ILC3 from SI LPLs of Cxcr6gfp/+ mice. Black bars indicate Cxcr6 expressing cells.
(legend continued on next page)
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CXCR6 Critical for ILC3 Localization and FunctionpathogenC. rodentium (Figure 2E). Previous studies have shown
that MHC II+CD11cmid cells, including intestinal monocytes and
macrophages, are also reduced in Cx3cr1gfp/gfp mice (Yu et al.,
2007), a result that we could confirm (Figure S2B). However, in-
testinal monocytes failed to express significant amounts of
Cxcl16, in contrast to CD11chi DCs (Figure S2C). Intestinal endo-
thelial cells expressed low amounts ofCxcl16 that was regulated
in a CX3CR1-dependent fashion (Figure S2D). CD64+ macro-
phages and Ly6C+ inflammatory monocytes also expressed
markedly lowerCxcl16 amounts comparedwith CD103CD11b+
intestinal DCs that were not significantly modified after
C. rodentium infection (Figures S2E–S2G).
To gain an insight into the mechanisms regulating Cxcl16
expression in CD11b+ intestinal DCs, we analyzed germ-free
C57BL/6 mice. We found that gut CD11b+ cells had reduced
Cxcl16 amounts in the absence of commensal flora suggesting
that microbial stimuli regulate chemokine expression (Figure 2F).
Together, these results link Cxcl16 expression in intestinal
CX3CR1+ DCs with steady-state homeostasis and IL-23-induc-
ible IL-22 production by gut ILC3.
The Chemokine Receptor CXCR6 Is Required for
Homeostasis of Intestinal ILC22 Subsets
Since CX3CR1 deficiency strongly affected CXCL16 expression
by intestinal myeloid cells, we next assessed how lack of
CXCL16 function might impact on intestinal ILC3 subset homeo-
stasis and function. We therefore screened gut ILC3 subsets
(NKp46+, CD4+, DN) for expression of chemokine receptors (Fig-
ure 3A).Ccr6,Ccr7, andCcr9were expressed in low amounts by
ILC3 subsets, while Cxcr6 was highly expressed, especially in
NKp46+ ILC3s (Figure 3A).
We confirmed these results using mice bearing a targeted
insertion of a GFP-reporter into the Cxcr6 locus (Cxcr6gfp/+
mice) (Geissmann et al., 2005). ILC subsets differentially ex-
pressing NKp46 and CD4 transcribed the Cxcr6 locus with the
vast majority of NKp46+ and CD4+ cells expressing CXCR6,
while the DN cells harbored both CXCR6+ and CXCR6mid cells
(Figure 3B). GFP expression was highest in NKp46+ ILC3s and
on a subset of DN ILC3s and lower on CD4+ ILC3s (Figure 3B)
suggesting that CXCR6 expression could be correlated with dif-
ferential homing and/or function of ILC3 subsets. Along these
lines, IL-23-stimulated IL-22 production from both NKp46+ and
CD4+ ILCs was clearly correlated with CXCR6 expression (Fig-
ure 3C). IL-22+ cells were restricted to CXCR6hi cells, whereas
IL-22+ cells in the DN subset were either CXCR6hi or CXCR6
(Figure 3D). To gain insight into the mechanisms that could
explain the differential IL-22 expression by CXCR6 subsets, we
performed molecular analysis of ILC3 subsets that were GFP+
or GFP. Rorc expression was enriched in GFP+ ILC3s that ex-
pressed NKp46 or CD4 and was detected in both GFP+ and
GFP DN ILC3s (Figure 3E). Moreover, Il23r expression was(E) Analysis of Rorc and Il23r expression in sorted Cxcr6 (GFP) or Cxcr6+ (GFP
(F) Analysis of ILC3 subsets in SI LPLs from Cxcr6gfp/+ and Cxcr6gfp/gfp mice. Num
and NKp46-expressing ILC3 subsets (right panels).
(G) Absolute numbers of total ILC3, NKp46+, CD4+, and DN ILC3 subsets from S
(H) Analysis of IL-22 expression in intestinal ILC subsets from Cxcr6gfp/+ and Cxc
(I) Absolute numbers of IL-22 producing ILC3 subsets inCxcr6gfp/+ andCxcr6gfp/gfp
each genotype. *p value < 0.05. **p < 0.01. See also Figure S3.
Ialso strongly correlated with GFP expression (Figure 3E) sug-
gesting that CXCR6-expressing ILC3s are the major responders
to IL-23 during inflammation and infection. Incubation of lamina
propria (LP) cells from Cxcr6gfp/+ mice with CXCL16 did not alter
the proportions of GFP+ ILC3s and addition of CXCL16 to IL-23-
stimulated cultures did not affect the percentages of IL-22-pro-
ducing cells (Figure S3A), suggesting that CXCL16 does not
act as a maturation or costimulatory factor for intestinal ILC3s.
To assess the effect of CXCR6 deficiency on ILC subset distri-
bution, we analyzed Cxcr6gfp/gfp mice as the GFP reporter inser-
tion simultaneously inactivates the corresponding Cxcr6 allele
(Geissmann et al., 2005). CXCR6 deficiency does not affect
RORgt+ ILC differentiation during embryogenesis (Possot
et al., 2011) and Cxcr6gfp/gfp mice demonstrated normal devel-
opment of Peyer’s patches and lymph nodes (data not shown).
Absolute numbers of ILC3s were reduced byCxcr6 ablation (Fig-
ures 3F and 3G), and moreover, the ILC3 subset distribution was
altered, with a clear reduction in the proportions and absolute
numbers of NKp46+ cells (Figure 3G).
Intestinal ILC3s from mice deficient in Cxcr6 exhibited
reduced IL-22 production ex vivo. IL-23-stimulated IL-22 pro-
duction from NKp46+ cells was strongly reduced, whereas IL-
22 production from CD4+ cells and DN cells was not significantly
modified (Figure 3H). When calculating absolute numbers of IL-
22+ cells, the selective negative effect of Cxcr6 deletion against
NKp46+ IL-22+ cells was clear: over 95% of these cells were lost,
in contrast with numbers of IL-22+ CD4 and DN cells that re-
mained essentially unchanged in Cxcr6gfp/gfp mice (Figure 3I).
Together, these results demonstrate that CXCR6 expression
marks IL-23 responsive IL-22-producing ILC3 subsets and that
CXCR6 plays a critical role in the homeostasis of intestinal
NKp46+ ILC3s.
We also analyzed the effects of Cxcr6 deletion on intestinal
CD4+ T cells. We found no differences in the absolute numbers
of gut CD4+ T cells in Cxcr6gfp/+ versus Cxcr6gfp/gfp mice (Fig-
ure S3B). About 18% of intestinal CD4+ T cells expressed
GFP+ and there was no reduction in IL-22+ T cells in the absence
of CXCR6 (Figures S3C and S3D).
Selective Loss of IL-22-Dependent Effectors in the
Villus Epithelium of Cxcr6gfp/gfp Mice
We next assessed the impact of CXCR6 deficiency on the tissue
localization of RORgt+ ILC in the small intestine. Previous studies
have localized NKp46+RORgt+ ILC to the intestinal villus,
whereas CD4+RORgt+ and DN RORgt+ ILCs are clustered
in cryptopatches and isolated lymphoid follicles (ILF) (Luci
et al., 2009; Satoh-Takayama et al., 2011; Satoh-Takayama
et al., 2008; Sawa et al., 2010). This dichotomy of ILC3 posi-
tioning suggests different mechanisms for anatomical partition-
ing within the intestine. Using Cxcr6gfp/+ mice, we found that
CD3CXCR6+RORgt+ ILCs were distributed in anatomically+) ILC subsets from Rag2–/–Cxcr6gfp/+ mice.
bers indicate percent of gated CD3–CD127+RORgt+ cells (left panels) and CD4
I LPLs of Cxcr6gfp/+ and Cxcr6gfp/gfp mice.
r6gfp/gfp mice. SI LPLs were stimulated with IL-23 for 4 hr in vitro.
mice. Data are representative of >3 experimentswith n = 4–6mice analyzed for
mmunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc. 781
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Figure 4. Loss of IL-22-Mediated Responses in the Villus Epithelium of Cxcr6gfp/gfp Mice
(A) Immunohistological analysis of CXCR6+ ILC3 in small intestine from Cxcr6gfp/+ and Cxcr6gfp/gfp mice. Sections were stained with DAPI (blue), anti-GFP
(CXCR6; green), anti-RORgt (red), and anti-CD3 (white). Scale bar represents 20 mm. Original magnification: 320. Representative results in one of three
independent experiments are shown.
(B) Analysis of Reg3g, Reg3b, and Lcn2 expression by SI LPLs and intestinal epithelial cells (IEC) isolated from Rag2–/–Cxcr6gfp/+ and Rag2–/–Cxcr6gfp/gfp mice
(n = 5 mice of each genotype). Results are normalized to Gapdh. *p value < 0.05.
(C) Immunohistochemistry of villus epithelium (small intestine) from Cxcr6gfp/+ and Cxcr6gfp/gfp mice stained with/without RegIIIg-specific antibodies and
counterstained with hematoxylin. Scale bar represents 1 mm.
(D) Transwell migration assay using SI LPLs by Rag2–/–Cxcr6gfp/+ and Rag2–/–Cxcr6gfp/gfp mice. Cells were cultured with or without ligand Cxcl16 (5, 10, and
100 ng/ml). For analysis, cells were gated on ILC3 (CD3CD127+RORgt+) cells. Data are compiled from six independent experiments. *p value < 0.05. **p < 0.01.
See also Figure S4.
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CXCR6 Critical for ILC3 Localization and Functiondistinct regions (Figure 4A). Clusters of RORgt+ ILCs were found
in patches at the base of the intestinal villi that resembled
cryptopatches or ILF. These include CD4+ LTi-like cells that ex-
press CCR6 (Klose et al., 2013; Sawa et al., 2010); a fraction of
these RORgt+ ILCs coexpressed CXCR6. A second subset of782 Immunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc.RORgt+CXCR6+ ILCs was found interspersed throughout the
LP (Figure 4A) that includes NKp46+ ILC3 (Satoh-Takayama
et al., 2008). Intestinal CXCR6+ T cells could also be detected
in the LP where a fraction expressed RORgt (Figure 4A). In
Cxcr6gfp/gfp mice, clusters of RORgt+ ILC were retained;
Immunity
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(Figure 4A). Some GFP+ T cells remained in the villi, although
these also lacked detectable RORgt expression. These results
demonstrate that CXCR6 expression is essential for homeosta-
sis of RORgt+ ILCs in the villus LP, but not for ILC3 in crypto-
patches or ILF.
Expression of antimicrobial peptides Reg3b, Reg3g, and Lcn2
in intestinal epithelial cells (IECs) was strongly reduced in
the absence of CXCR6 (Figure 4B). Immunohistological analysis
of RegIIIg protein revealed obvious epithelial cell staining
throughout the intestinal villus in Cxcr6gfp/+ mice whereas this
staining was markedly reduced in Cxcr6gfp/gfp mice (Figure 4C).
These results demonstrate that RORgt+ ILCs and T cells in the
LP are critical for maintaining IL-22-dependent effector proteins
required for barrier protection. Moreover, these results suggest
that RORgt+ innate and adaptive lymphocytes use distinct
mechanisms for their homeostasis in the villus versus crypto-
patch and ILF regions.
Despite their absence from the intestinal villus, absolute
numbers of intestinal RORgt+ T cells were not altered in the
absence of CXCR6 (Figure S4A). We next assessed whether
the absence of villus RORgt+ ILCs and T cells in CXCR6 defi-
ciency were linked. We analyzed ILC3 distribution in Rag2/
mice that were either CXCR6-sufficient (Rag2/Cxcr6gfp/+) or
-deficient (Rag2/Cxcr6gfp/gfp). We found that CXCR6+ ILC3s
normally localized within the villus in the absence of T cells but
that ILC3s were missing from Rag2/mice lacking CXCR6 (Fig-
ure S4B). This result suggests that CXCR6 was directly required
to localize ILC3 within the intestinal lamina propria.
We next assessed the migratory capacities of ILC3 subsets
from Cxcr6gfp/+ mice mice to CXCL16 using a transwell assay.
We found that NKp46+ ILC3s selectively migrated in a dose-
dependent fashion to CXCL16, whereas CD4+ and DN subsets
did not (Figure 4D). As expected, migrating NKp46+ ILC3 were
GFP+ (Figure S4C). These results demonstrate that NKp46+
ILC3 express functional CXCR6 that allows their migration to-
ward CXCL16 and that CXCR6 is required for normal anatomical
localization of NKp46+ ILC3 within the intestinal lamina propria.
While DN ILC3s do not migrate to CXCL16, this ligand might
trigger other functions within this ILC3 subset.
CXCR6 Is Required for IL-22-Dependent Mucosal
Defense against Bacterial Infection
Since defense against C. rodentium induces high amounts of
IL-22 that are critical for host survival (Zheng et al., 2008), this
model provides a means to assess the role for innate and adap-
tive IL-22 sources for immunity against intestinal pathogens.
When analyzing the early immune response to C. rodentium
(day 5 postinfection), we found that intestinal NKp46+, and to a
lesser extent ‘‘DN’’ ILC3s, were the predominant innate source
of intestinal IL-22 (Figures S5A–S5D). To assess the role for
CXCR6+ ILC3s in C. rodentium defense, we compared the
response of Rag2/Cxcr6gfp/+ and Rag2/Cxcr6gfp/gfp mice
to this enteric pathogen. In Cxcr6gfp/+ mice, IL-22 production
was induced in all ILC3 subsets (NKp46, CD4, ‘‘DN’’) in response
to C. rodentium and IL-22 expression was correlated with
CXCR6 expression (Figure 5A; note that lamina propria lympho-
cytes (LPLs) were not restimulated with IL-23 in vitro). As was the
case in Rag-competent hosts (Figures S5A–S5D), the increase inIabsolute numbers of IL-22-producing cells was largely due to
NKp46+ ILC3s, whereas numbers of IL-22+ CD4 remained stable
and ‘‘DN’’ cells were slightly increased in this model of ‘‘innate-
only’’ immunity (Figure 5B, left panel). In contrast, the absolute
numbers of IL-22+ ILC3s did not increase in C. rodentium-in-
fected mice lacking CXCR6 expression (Figure 5B, right panel).
As loss of CXCR6 selectively ablated ILC3s in the villus lamina
propria in both Rag-competent and Rag-deficient mice (Fig-
ure 4A; Figure S4B), we assessed whether residual IL-22-pro-
duction would be sufficient to protect the host against infection
by C. rodentium. Rag2/Cxcr6gfp/+ and Rag2/Cxcr6gfp/gfp
mice were gavaged with bioluminescent C. rodentium (Wiles
et al., 2006) and survival was assessed. We also noninvasively
monitored C. rodentium growth during the infection (Serafini
et al., 2014). As expected (Satoh-Takayama et al., 2008; Zheng
et al., 2008), control Rag2/ and Rag2/Cxcr6gfp/+ mice re-
sisted infection up to 40 days; in contrast, Rag2/Cxcr6gfp/gfp
mice were highly susceptible and succumbed to infection within
2 weeks (Figure 5C). Accordingly, C. rodentium growth was
controlled in CXCR6-competent Rag2/ mice, whereas infec-
tion spread in Rag2/Cxcr6gfp/gfp mice (Figures 5D and 5E).
Similar results were obtained in Rag-competent hosts lacking
Cxcr6 (Figures S5E and S5F). During C. rodentium infection,
inducible IL-22 triggers production of antimicrobial peptides
from intestinal epithelial cells (Zheng et al., 2008). We found
that intestinal epithelial cell (IEC) expression of Reg3b and
Reg3g were clearly reduced in Rag2/Cxcr6gfp/gfp mice
compared to Rag2/Cxcr6gfp/+ mice at day 5 postinfection (Fig-
ure 5F) and IL-22 secretion from small intestine LP cells was
reduced in Rag2/Cxcr6gfp/gfp mice (Figure 5G). Moreover,
administration of recombinant IL-22 to C. rodentium-infected
Rag2/Cxcr6gfp/gfp mice or Cxcr6gfp/gfp mice could protect
against early demise (Figure 5H; Figure S5G), strongly impli-
cating defective IL-22 production in the heightened susceptibility
of thesemice to this pathogen. Taken together, our results define
a coordinated crosstalk between CX3CR1+ DC and ILC3 sub-
sets that orchestrates IL-22 production within discrete regions
of the intestinal epithelium. CXCL16/CXCR6 interactions repre-
sent a critical mechanism to ensure mucosal barrier function
under steady-state conditions and in response to infection.
DISCUSSION
A diverse set of ILCs regulates immune responses to pathogens
at mucosal barriers (reviewed in Spits et al., 2013; Spits and
Di Santo, 2011). While the mechanisms that control the effector
functions of distinct ILC subsets are beginning to be unrav-
eled, our understanding of the mechanisms that control ILC
localization within different organs and tissues remain limited
(Walker et al., 2013). Moreover, the functional consequences of
distinct ILC distribution patterns are not understood. Our results
shed light on these questions by demonstrating the critical
requirement for CXCR6 in the homeostasis and localization
of IL-22 producing cells within the intestinal LP, especially
for NKp46+ ILC3s. The increased susceptibility of Cxcr6gfp/gfp
mice to C. rodentium infection highlights the importance of
CXCL16-mediated tissue distribution of IL-22 producing subsets
that are required for early host defense against pathogenic
microbes.mmunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc. 783
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Figure 5. CXCR6 Is Required for ILC3-Mediated Mucosal Defense against Bacterial Infection
(A) Analysis of IL-22+ ILC3 in SI LPLs following Citrobacter rodentium infection. Rag2–/–Cxcr6gfp/+ mice were orally gavaged with 1 3 109 bacteria. Numbers
indicate percent positive cells ILC3 subsets. Representative results from four independent experiments.
(B) Absolute numbers of IL-22 producing ILC (CD127+CD3–) in SI LPLs of Rag2–/–Cxcr6gfp/+ (left panel) and Rag2–/–Cxcr6gfp/gfp mice (right panel) at steady-state
(open bars) or following C. rodentium infection (day 5 postinfection; black bars). SI LPLs were cultured for 4 hr without stimulation in the presence of GolgiPlug.
Four mice of each genotype were analyzed in two independent experiments.
(C) Survival after C. rodentium infection in Rag2–/–, Rag2–/–Cxcr6gfp/+, and Rag2–/–Cxcr6gfp/gfp mice. Mice were orally gavaged with 1 3 109 bacteria. Data are
representative of four independent experiments (n = 6 for Rag2/ and n = 9 for Rag2/Cxcr6gfp/+mice, n = 10 for Rag2/Cxcr6gfp/gfp mice).
(legend continued on next page)
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CXCR6 Critical for ILC3 Localization and FunctionPrevious studies used gene profiling to identify several che-
mokine receptors that are expressed by NKp46+ cells and
CD4+ RORgt+ ILC3 subsets (Cella et al., 2009; Luci et al.,
2009). However, our understanding of the functional importance
of these receptors for ILC3 homeostasis and function is not com-
plete. CXCR5 ablation has been shown to affect LTi function,
with defects in lymph nodes and Payer’s patches development,
while CCR7 expression on LTi cells has been suggested to rein-
force lymphoid tissue organogenesis through reciprocal activa-
tion by mesenchymal stromal cells that express CCL19 (Ohl
et al., 2003). CCR6 is expressed by CD4+ ILC3 and by a subset
of DN ILC3s (Klose et al., 2013; Sawa et al., 2010). Although the
absence of CCR6 does not affect LN or Peyer’s patch formation,
CCR6 ligands are involved in cryptopatch and ILF maturation in
the intestine that play a direct role in regulating commensal com-
munities (Bouskra et al., 2008). In contrast, CCR6 NKp46+
ILC3s develop independently of this receptor (Satoh-Takayama
et al., 2008; Sawa et al., 2010).
A previous report identified CXCR6 as a marker of RORgt+
precursors in the fetal liver and spleen (Possot et al., 2011). While
the absence of CXCR6 did not affect development of fetal
RORgt+ cells, this receptor has a critical role in homeostasis of
the NKp46+ ILC3 subset in adult mice. The age-dependent effect
of CXCR6 may be explained by chemokine receptor redun-
dancy; RORgt+ fetal lymphoid precursors were shown to ex-
press CXCR5, CCR6, andCCR7 (Possot et al., 2011). In contrast,
CXCR6might have itsmain role in the development of certain ILC
subsets that appear after birth, such as NKp46+ ILC3s (Sawa
et al., 2010).
We found that CXCR6 expression marked a functionally
mature subset within intestinal ILCs. IL-22 production was corre-
lated with Cxcr6 expression in NKp46+, CD4+, and a subset of
DN ILC3s. These CXCR6+ cells had higher expression of Rorc
and Il23r that could explain their heightened capacity to produce
IL-22. Themolecular mechanisms that control chemokine recep-
tor expression in ILCs are not well defined. Previous studies have
shown that CCR6 and IL-23R are RORgt-dependent target
genes (Yamazaki et al., 2008), and we found that Cxcr6 expres-
sion correlated with Rorc in NKp46+ and CD4+ ILC3 subsets. As
such, Rorc might program a constellation of surface receptors
that allow ILC3 subsets to distribute within the intestine, ready
to receive the relevant soluble signals from sentinel cells for their
activation. Still, additional transcriptional regulators must be
operating because ILC3 subsets differentially express CCR6
and CXCR6 that apparently allows them to home to distinct
gut microenvironments.
Whatever the mechanism, the ability of CXCR6-expressing
ILCs to produce IL-22 would ultimately target this factor to the
corresponding CXCL16-rich regions within the intestine. The(D) In vivo growth dynamics of bioluminescent C. rodentium. Rag2/Cxcr6gfp/+ a
bacterial localization was determined by Xenogen imaging. Pseudo color images
(E) Average radiance analysis. Data are compiled from three independent experi
(F) Analysis of Reg3g and Reg3b expression by SI LPLs or SI IECs from Rag2/C
of each genotype were analyzed.
(G) IL-22 secretion by SI LPLs from Rag2/Cxcr6gfp/+ and Rag2/Cxcr6gfp/gfp m
collected after 24 hr culture without stimulation and IL-22 measured by ELISA.
(H) Effect of recombinant IL-22 on survival and loss of body weight in C. rodentiu
mice each PBS or rIL-22 treated). 1 mg of rIL-22 was injected intraperitoneally ev
Itransmembrane-bound CXCL16 is expressed in many cell types
(Matloubian et al., 2000), including both hematopoietic (macro-
phages) and nonhematopoietic (epithelial, endothelial) lineages
that vary during ontogeny. We found that CD11b+ intestinal
DCs were the major Cxcl16 expressing cells in the adult
under steady-state conditions. In addition, Cxcl16 expression
in these cells increased following intestinal infection, in agree-
ment with previous studies (Tohyama et al., 2007). As CD11b+
inflammatory phagocytes also express Il23a under these condi-
tions, CXCR6+ ILCs that would be attracted to CD11b+ DCs
would also receive signals promoting IL-22 production that
could have a role in tissue regeneration and recovery from
inflammation.
Several studies have investigated the cellular sources of IL-22
in mucosal tissues (reviewed in (Sonnenberg et al., 2011)). Early
studies have demonstrated the importance of T cell receptor gd+
cells that could be triggered by IL-1b and IL-23 (Sutton et al.,
2009). More recently, ILC that produce IL-22 have been impli-
cated in protection against enteropathogens and in recovery
following epithelial damage (Zenewicz et al., 2008; Zheng
et al., 2008). Following C. rodentium infection, increased propor-
tions of IL-22+ ILCs have been identified in the mLN, and in the
crypts, villus LP, and epithelium of the small and large intestine
(Cella et al., 2009; Lee et al., 2012; Satoh-Takayama et al.,
2008; Sonnenberg et al., 2011).
We focused on the small intestine LP as this tissue harbors an
abundant and diverse set of ILC subsets that produce IL-22. Our
results demonstrate that CXCR6 plays an essential role in local-
izing IL-22-producing RORgt+ ILCs (especially NKp46+ ILC3)
within the villus LP. This might be due to reduced ILC3 recruit-
ment from the circulation or from poor maintenance of these
cells once resident in the tissues. In contrast, the formation of
RORgt+ ILC clusters remained intact. The consequences of
this perturbed ILC topography included a marked reduction in
overall IL-22 production and a corresponding decrease in the
production of protective antimicrobial peptides by the intestinal
epithelium. These observations suggest different mechanisms
that control ILC3 distribution within the intestine and open the
possibility for different roles for IL-22 production from RORgt+
ILCs present in the villus LP and the crypts.
Our results demonstrate the important role for localized IL-22
production in the villus LP in maintaining epithelial defense and
mucosal barrier function and identify CXCR6 expression as a
key mechanism required for this function. IL-22 production in
crypt structures might serve a similar function, and in addition,
is proposed to influence ILF maturation (Ota et al., 2011) and
subsequent antibody responses. The absence of CXCR6 re-
sulted in a severe reduction in IL-22 expression. Still, in vitro cul-
ture of isolated LPLs demonstrated that IL-22 could be inducednd Rag2/Cxcr6gfp/gfp mice were orally gavaged with 109 bacteria and in vivo
are shown (scale bar, photon/s/cm2/sr).
ments with six mice of each genotype analyzed.
xcr6gfp/+ and Rag2/Cxcr6gfp/gfp mice infected with C. rodentium. Three mice
ice at steady-state or following infection with C. rodentium. Supernatants were
m-infected Rag2/Cxcr6gfp/+ (n = 6 mice) and Rag2/Cxcr6gfp/gfp mice (n = 6
ery 2 days postinfection. *p value < 0.05. **p value < 0.01. See also Figure S5.
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and histological analysis revealed the presence of RORgt+
ILC3 clusters in the absence of CXCR6. It is possible that the
triggers required for IL-22 production, such as IL-23, are not
available in these clusters in vivo, thereby explaining the quasi
absence of IL-22 expression after C. rodentium infection.
Previous reports have associated abnormal formation of
lymphoid structures secondary to deficiencies in lymphotoxin-
b receptor (LTbR) and deficiencies in IL-22 production by intes-
tinal ILC subsets to defects in Notch signaling (Lee et al., 2012;
Ota et al., 2011). The apparent normal development of lymphoid
structures in CXCR6-deficientmice demonstrates that additional
mechanisms control intestinal IL-22 production independent of
organized lymphoid tissues. While a role for cryptopatches or
ILFs in priming IL-22 production in intestinal ILC is possible (via
LTbR-dependent IL-23 from DCs; Tumanov et al., 2011), our re-
sults demonstrate that CXCR6 expression is critical for IL-22+
ILC distribution throughout the villus LP. ILF are disorganized
inCcr6/mice suggesting that CCR6 ligands attract and locally
retain CCR6+ ILC3s (Sawa et al., 2010). Because CCR6NKp46+
cells do not accumulate in cryptopatches or ILFs (Satoh-Ta-
kayama et al., 2011; Satoh-Takayama et al., 2008; Sawa et al.,
2010), our results highlight two independent chemokine path-
ways (CXCR6, CCR6) that orchestrate and segregate ILC3
subset localization within the intestine.
EXPERIMENTAL PROCEDURES
Mice
Cx3cr1gfp/+ (Jung et al., 2000), Cxcr6gfp/+ (Geissmann et al., 2005), Rorcgfp/+
(Sawa et al., 2010), and Ncr1gfp/+ mice (Gazit et al., 2006) were on the
C57BL/6 background. All mice were housed under the specific pathogen-
free condition at the Institut Pasteur, provided with food and water ad libitum
and were analyzed at 8–18 weeks of age. Littermates were used for all exper-
iments. Animal experiments followed the guidelines provided by the Animal
Care Use Committee of the Institut Pasteur andwere performed in accordance
with French law (authorizations A7515-06, A7515-07, and 75-579).
Flow Cytometry Analysis
LPLs were extracted using collagenase digestions and density gradient centri-
fugation as described (Satoh-Takayama et al., 2008). Cell surface and intracel-
lular staining was performed as described (Satoh-Takayama et al., 2011) with
fluorochrome-coupled antibodies (Table S1). Epithelial cells were released us-
ing EDTA as described (Serafini et al., 2014). FACS Fortessa and AriaIII (BD
Biosciences) were used for cell sorting and acquisition, respectively, and all
flow cytometry data were analyzed with FlowJo (TreeStar). Mouse IL-22 ELISA
was from R&D Systems.
Immunohistology
Immunohistological analysis was performed on formalin-fixed material and
8 mm frozen sections were stained using fluorochrome-coupled antibodies
as described (Satoh-Takayama et al., 2008). For RegIIIg staining, endogenous
peroxydase activity was quenched using PBS containing 0.3%H2O2. Sections
were stained with rabbit anti-RegIIIg (Abgent), revealed peroxydase-coupled
anti-rabbit immunoglobulin, and developed with DAB (Dako). Slides were
counterstained with hematoxylin solution (Sigma-Aldrich).
Gene-Expression Analysis
RNA was isolated with the RNAeasy Micro Kit (QIAGEN) and amplified with
MessageBooster (Tebu Bio). cDNAwas generated with Superscript III Reverse
Transcriptase (Invitrogen) and quantitative PCR performed with SYBR Green
MasterMix (QIAGEN) with specific primers (EasyOligo; Sigma Aldrich; Table
S2) or ChemokineSuperArray (QIAGEN). Samples were normalized to Gapdh
expression.786 Immunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc.Transwell Assay
Transwell chambers (5 mm,Costar) were blockedwith 1%BSAand coatedwith
recombinant CXCL16 (R&D Systems). Total SI LPL (106 cells) from
Rag2–/–Cxcr6gfp/+ orRag2–/–Cxcr6gfp/gfpmicewere plated in replicate in the up-
per chamber and cultured for 2 hr at 37C. ILC3 subsets in the migrating cells
were analyzed by FACS after cell surface staining as indicated above. Chemo-
taxis index indicates the migration ratio compared to wells without CXCL16.
C. rodentium Infection and Xenogen Imaging
Log phase cultures of BLI-C. rodentium (Wiles et al., 2006) were washed in
PBS andmice were orally infected with 109 cfu as described (Satoh-Takayama
et al., 2008). For in vivo tracking of C. rodentium, mice were anesthetized with
ketamine (Imalgene 1000) and xylazine (Rompun). Prior to BLI, the abdominal
region was shaved and mice were placed in a confinement box (TEM SEGA)
and imaged using an IVIS 100 system (Caliper Life Sciences). Image acquisi-
tion and analysis were performed with the Living Image 3.2 software (Caliper
Life Sciences) as described (Serafini et al., 2014).
Statistical Analysis
Experimental results are reported as mean ± SEM. Statistical differences be-
tween groups were determined with the unpaired Student’s t test. p values <
0.05 were considered significant. Significance for survival rates of Kaplan-Me-
ier curves was calculated with the log rank test. All data were analyzed with
Graphpad Prism software.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and two tables and can be
found with this article online at http://dx.doi.org/10.1016/j.immuni.2014.10.
007.
AUTHOR CONTRIBUTIONS
N.S.-T., N.S., and T.V. designed, performed, and analyzed experiments; A.R.
contributed to setting up the Xenogen technology; J.-C. R. and G.F. provided
critical reagents and advice; J.P.D. designed and directed the study; N.S.-T.
and J.P.D. wrote the manuscript with help from all of the authors.
ACKNOWLEDGMENTS
We thank O. Mandelboim (Hebrew University, Jerusalem), F. Geissmann
(Necker Hospital, Paris) and G. Eberl (Institut Pasteur) for Ncr1gfp/+ mice,
Cxcr6gfp/Cx3cr1gfp mice, and Rorcgfp mice, respectively. N.S.-T. was the
recipient of fellowship from Japan Society for the Promotion of Science
(JSPS), Japan. Supported by the Institut Pasteur, Inserm, and the ANR
(Gut_ILC).
Received: June 13, 2013
Accepted: October 16, 2014
Published: November 6, 2014
REFERENCES
Aujla, S.J., Chan, Y.R., Zheng, M., Fei, M., Askew, D.J., Pociask, D.A.,
Reinhart, T.A., McAllister, F., Edeal, J., Gaus, K., et al. (2008). IL-22 mediates
mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med.
14, 275–281.
Bernink, J.H., Peters, C.P., Munneke, M., te Velde, A.A., Meijer, S.L., Weijer,
K., Hreggvidsdottir, H.S., Heinsbroek, S.E., Legrand, N., Buskens, C.J.,
et al. (2013). Human type 1 innate lymphoid cells accumulate in inflamed
mucosal tissues. Nat. Immunol. 14, 221–229.
Bouskra, D., Bre´zillon, C., Be´rard, M., Werts, C., Varona, R., Boneca, I.G., and
Eberl, G. (2008). Lymphoid tissue genesis induced by commensals through
NOD1 regulates intestinal homeostasis. Nature 456, 507–510.
Buonocore, S., Ahern, P.P., Uhlig, H.H., Ivanov, I.I., Littman, D.R., Maloy, K.J.,
and Powrie, F. (2010). Innate lymphoid cells drive interleukin-23-dependent
innate intestinal pathology. Nature 464, 1371–1375.
Immunity
CXCR6 Critical for ILC3 Localization and FunctionCella, M., Fuchs, A., Vermi, W., Facchetti, F., Otero, K., Lennerz, J.K.M.,
Doherty, J.M., Mills, J.C., and Colonna, M. (2009). A human natural killer cell
subset provides an innate source of IL-22 for mucosal immunity. Nature 457,
722–725.
Cerovic, V., Houston, S.A., Scott, C.L., Aumeunier, A., Yrlid, U., Mowat, A.M.,
and Milling, S.W. (2013). Intestinal CD103(-) dendritic cells migrate in lymph
and prime effector T cells. Mucosal Immunol. 6, 104–113.
Chieppa, M., Rescigno, M., Huang, A.Y., and Germain, R.N. (2006). Dynamic
imaging of dendritic cell extension into the small bowel lumen in response to
epithelial cell TLR engagement. J. Exp. Med. 203, 2841–2852.
Coombes, J.L., Siddiqui, K.R., Arancibia-Ca´rcamo, C.V., Hall, J., Sun, C.M.,
Belkaid, Y., and Powrie, F. (2007). A functionally specialized population of
mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and
retinoic acid-dependent mechanism. J. Exp. Med. 204, 1757–1764.
Cox, J.H., Kljavin, N.M., Ota, N., Leonard, J., Roose-Girma, M., Diehl, L.,
Ouyang, W., and Ghilardi, N. (2012). Opposing consequences of IL-23
signaling mediated by innate and adaptive cells in chemically induced colitis
in mice. Mucosal Immunol. 5, 99–109.
Cupedo, T., Crellin, N.K., Papazian, N., Rombouts, E.J., Weijer, K., Grogan,
J.L., Fibbe, W.E., Cornelissen, J.J., and Spits, H. (2009). Human fetal lymphoid
tissue-inducer cells are interleukin 17-producing precursors to RORC+
CD127+ natural killer-like cells. Nat. Immunol. 10, 66–74.
Gazit, R., Gruda, R., Elboim, M., Arnon, T.I., Katz, G., Achdout, H., Hanna, J.,
Qimron, U., Landau, G., Greenbaum, E., et al. (2006). Lethal influenza infection
in the absence of the natural killer cell receptor gene Ncr1. Nat. Immunol. 7,
517–523.
Geissmann, F., Cameron, T.O., Sidobre, S., Manlongat, N., Kronenberg, M.,
Briskin, M.J., Dustin, M.L., and Littman, D.R. (2005). Intravascular immune sur-
veillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113.
Gordon, S.M., Chaix, J., Rupp, L.J., Wu, J., Madera, S., Sun, J.C., Lindsten, T.,
and Reiner, S.L. (2012). The transcription factors T-bet and Eomes control key
checkpoints of natural killer cell maturation. Immunity 36, 55–67.
Jung, S., Aliberti, J., Graemmel, P., Sunshine, M.J., Kreutzberg, G.W., Sher, A.,
and Littman, D.R. (2000). Analysis of fractalkine receptor CX(3)CR1 function by
targeted deletion and green fluorescent protein reporter gene insertion. Mol.
Cell. Biol. 20, 4106–4114.
Kinnebrew, M.A., Buffie, C.G., Diehl, G.E., Zenewicz, L.A., Leiner, I., Hohl,
T.M., Flavell, R.A., Littman, D.R., and Pamer, E.G. (2012). Interleukin 23 pro-
duction by intestinal CD103(+)CD11b(+) dendritic cells in response to bacterial
flagellin enhances mucosal innate immune defense. Immunity 36, 276–287.
Klose, C.S., Kiss, E.A., Schwierzeck, V., Ebert, K., Hoyler, T., d’Hargues, Y.,
Go¨ppert, N., Croxford, A.L., Waisman, A., Tanriver, Y., and Diefenbach, A.
(2013). A T-bet gradient controls the fate and function of CCR6-RORgt+ innate
lymphoid cells. Nature 494, 261–265.
Klose, C.S., Flach, M., Mo¨hle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke, C.,
Pfeifer, D., Sexl, V., Fonseca-Pereira, D., et al. (2014). Differentiation of type 1
ILCs from a common progenitor to all helper-like innate lymphoid cell lineages.
Cell 157, 340–356.
Lee, J.S., Cella, M., McDonald, K.G., Garlanda, C., Kennedy, G.D., Nukaya,
M., Mantovani, A., Kopan, R., Bradfield, C.A., Newberry, R.D., and Colonna,
M. (2012). AHR drives the development of gut ILC22 cells and postnatal
lymphoid tissues via pathways dependent on and independent of Notch.
Nat. Immunol. 13, 144–151.
Longman, R.S., Diehl, G.E., Victorio, D.A., Huh, J.R., Galan, C., Miraldi, E.R.,
Swaminath, A., Bonneau, R., Scherl, E.J., and Littman, D.R. (2014).
CX3CR1
+ mononuclear phagocytes support colitis-associated innate
lymphoid cell production of IL-22. J. Exp. Med. 211, 1571–1583.
Luci, C., Reynders, A., Ivanov, I.I., Cognet, C., Chiche, L., Chasson, L.,
Hardwigsen, J., Anguiano, E., Banchereau, J., Chaussabel, D., et al. (2009).
Influence of the transcription factor RORgammat on the development of
NKp46+ cell populations in gut and skin. Nat. Immunol. 10, 75–82.
Manta, C., Heupel, E., Radulovic, K., Rossini, V., Garbi, N., Riedel, C.U., and
Niess, J.H. (2013). CX(3)CR1(+) macrophages support IL-22 production byIinnate lymphoid cells during infection with Citrobacter rodentium. Mucosal
Immunol. 6, 177–188.
Matloubian, M., David, A., Engel, S., Ryan, J.E., and Cyster, J.G. (2000). A
transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo. Nat.
Immunol. 1, 298–304.
Moro, K., Yamada, T., Tanabe, M., Takeuchi, T., Ikawa, T., Kawamoto, H.,
Furusawa, J., Ohtani, M., Fujii, H., and Koyasu, S. (2010). Innate production
of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid
cells. Nature 463, 540–544.
Neill, D.R., Wong, S.H., Bellosi, A., Flynn, R.J., Daly, M., Langford, T.K., Bucks,
C., Kane, C.M., Fallon, P.G., Pannell, R., et al. (2010). Nuocytes represent a
new innate effector leukocyte that mediates type-2 immunity. Nature 464,
1367–1370.
Niess, J.H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B.A., Vyas,
J.M., Boes, M., Ploegh, H.L., Fox, J.G., et al. (2005). CX3CR1-mediated den-
dritic cell access to the intestinal lumen and bacterial clearance. Science 307,
254–258.
Ohl, L., Henning, G., Krautwald, S., Lipp, M., Hardtke, S., Bernhardt, G., Pabst,
O., and Fo¨rster, R. (2003). Cooperating mechanisms of CXCR5 and CCR7 in
development and organization of secondary lymphoid organs. J. Exp. Med.
197, 1199–1204.
Ota, N., Wong, K., Valdez, P.A., Zheng, Y., Crellin, N.K., Diehl, L., and Ouyang,
W. (2011). IL-22 bridges the lymphotoxin pathway with the maintenance of
colonic lymphoid structures during infection with Citrobacter rodentium. Nat.
Immunol. 12, 941–948.
Possot, C., Schmutz, S., Chea, S., Boucontet, L., Louise, A., Cumano, A., and
Golub, R. (2011). Notch signaling is necessary for adult, but not fetal, develop-
ment of RORgt(+) innate lymphoid cells. Nat. Immunol. 12, 949–958.
Price, A.E., Liang, H.E., Sullivan, B.M., Reinhardt, R.L., Eisley, C.J., Erle, D.J.,
and Locksley, R.M. (2010). Systemically dispersed innate IL-13-expressing
cells in type 2 immunity. Proc. Natl. Acad. Sci. USA 107, 11489–11494.
Sabat, R., Ouyang, W., and Wolk, K. (2014). Therapeutic opportunities of the
IL-22-IL-22R1 system. Nat. Rev. Drug Discov. 13, 21–38.
Sanos, S.L., Bui, V.L., Mortha, A., Oberle, K., Heners, C., Johner, C., and
Diefenbach, A. (2009). RORgammat and commensal microflora are required
for the differentiation of mucosal interleukin 22-producing NKp46+ cells.
Nat. Immunol. 10, 83–91.
Satoh-Takayama, N., Vosshenrich, C.A., Lesjean-Pottier, S., Sawa, S.,
Lochner, M., Rattis, F., Mention, J.J., Thiam, K., Cerf-Bensussan, N.,
Mandelboim, O., et al. (2008). Microbial flora drives interleukin 22 production
in intestinal NKp46+ cells that provide innate mucosal immune defense.
Immunity 29, 958–970.
Satoh-Takayama, N., Lesjean-Pottier, S., Sawa, S., Vosshenrich, C.A.J., Eberl,
G., and Di Santo, J.P. (2011). Lymphotoxin-b receptor-independent develop-
ment of intestinal IL-22-producing NKp46+ innate lymphoid cells. Eur. J.
Immunol. 41, 780–786.
Satpathy, A.T., Brisen˜o, C.G., Lee, J.S., Ng, D., Manieri, N.A., Kc, W., Wu, X.,
Thomas, S.R., Lee, W.L., Turkoz, M., et al. (2013). Notch2-dependent classical
dendritic cells orchestrate intestinal immunity to attaching-and-effacing bac-
terial pathogens. Nat. Immunol. 14, 937–948.
Sawa, S., Cherrier, M., Lochner, M., Satoh-Takayama, N., Fehling, H.J.,
Langa, F., Di Santo, J.P., and Eberl, G. (2010). Lineage relationship analysis
of RORgammat+ innate lymphoid cells. Science 330, 665–669.
Serafini, N., Klein Wolterink, R.G., Satoh-Takayama, N., Xu, W., Vosshenrich,
C.A., Hendriks, R.W., and Di Santo, J.P. (2014). Gata3 drives development of
RORgt+ group 3 innate lymphoid cells. J. Exp. Med. 211, 199–208.
Sonnenberg, G.F., and Artis, D. (2012). Innate lymphoid cell interactions with
microbiota: implications for intestinal health and disease. Immunity 37,
601–610.
Sonnenberg, G.F., Fouser, L.A., and Artis, D. (2011). Border patrol: regulation
of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22.
Nat. Immunol. 12, 383–390.
Sonnenberg, G.F., Monticelli, L.A., Alenghat, T., Fung, T.C., Hutnick, N.A.,
Kunisawa, J., Shibata, N., Grunberg, S., Sinha, R., Zahm, A.M., et al. (2012).mmunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc. 787
Immunity
CXCR6 Critical for ILC3 Localization and FunctionInnate lymphoid cells promote anatomical containment of lymphoid-resident
commensal bacteria. Science 336, 1321–1325.
Spits, H., and Di Santo, J.P. (2011). The expanding family of innate lymphoid
cells: regulators and effectors of immunity and tissue remodeling. Nat.
Immunol. 12, 21–27.
Spits, H., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J.P., Eberl, G.,
Koyasu, S., Locksley, R.M., McKenzie, A.N., Mebius, R.E., et al. (2013).
Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev.
Immunol. 13, 145–149.
Sutton, C.E., Lalor, S.J., Sweeney, C.M., Brereton, C.F., Lavelle, E.C., and
Mills, K.H. (2009). Interleukin-1 and IL-23 induce innate IL-17 production
from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Immunity 31, 331–341.
Tohyama, M., Sayama, K., Komatsuzawa, H., Hanakawa, Y., Shirakata, Y.,
Dai, X., Yang, L., Tokumaru, S., Nagai, H., Hirakawa, S., et al. (2007).
CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes.
Int. Immunol. 19, 1095–1102.
Townsend, M.J., Weinmann, A.S., Matsuda, J.L., Salomon, R., Farnham, P.J.,
Biron, C.A., Gapin, L., and Glimcher, L.H. (2004). T-bet regulates the terminal
maturation and homeostasis of NK and Valpha14i NKT cells. Immunity 20,
477–494.
Tumanov, A.V., Koroleva, E.P., Guo, X., Wang, Y., Kruglov, A., Nedospasov,
S., and Fu, Y.X. (2011). Lymphotoxin controls the IL-22 protection pathway
in gut innate lymphoid cells during mucosal pathogen challenge. Cell Host
Microbe 10, 44–53.788 Immunity 41, 776–788, November 20, 2014 ª2014 Elsevier Inc.Varol, C., Zigmond, E., and Jung, S. (2010). Securing the immune tightrope:
mononuclear phagocytes in the intestinal lamina propria. Nat. Rev. Immunol.
10, 415–426.
Walker, J.A., Barlow, J.L., and McKenzie, A.N. (2013). Innate lymphoid cells—
how did we miss them? Nat. Rev. Immunol. 13, 75–87.
Wiles, S., Pickard, K.M., Peng, K., MacDonald, T.T., and Frankel, G. (2006).
In vivo bioluminescence imaging of the murine pathogen Citrobacter roden-
tium. Infect. Immun. 74, 5391–5396.
Wong, S.H., Walker, J.A., Jolin, H.E., Drynan, L.F., Hams, E., Camelo, A.,
Barlow, J.L., Neill, D.R., Panova, V., Koch, U., et al. (2012). Transcription factor
RORa is critical for nuocyte development. Nat. Immunol. 13, 229–236.
Yamazaki, T., Yang, X.O., Chung, Y., Fukunaga, A., Nurieva, R., Pappu, B.,
Martin-Orozco, N., Kang, H.S., Ma, L., Panopoulos, A.D., et al. (2008). CCR6
regulates the migration of inflammatory and regulatory T cells. J. Immunol.
181, 8391–8401.
Yu, Y.R., Fong, A.M., Combadiere, C., Gao, J.L., Murphy, P.M., and Patel, D.D.
(2007). Defective antitumor responses in CX3CR1-deficient mice. Int. J.
Cancer 121, 316–322.
Zenewicz, L.A., Yancopoulos, G.D., Valenzuela, D.M., Murphy, A.J., Stevens,
S., and Flavell, R.A. (2008). Innate and adaptive interleukin-22 protects mice
from inflammatory bowel disease. Immunity 29, 947–957.
Zheng, Y., Valdez, P.A., Danilenko, D.M., Hu, Y., Sa, S.M., Gong, Q., Abbas,
A.R., Modrusan, Z., Ghilardi, N., de Sauvage, F.J., and Ouyang, W. (2008).
Interleukin-22mediates early host defense against attaching and effacing bac-
terial pathogens. Nat. Med. 14, 282–289.
